RU2629840C2 - Контрастное вещество для визуализации перфузии миокарда - Google Patents

Контрастное вещество для визуализации перфузии миокарда Download PDF

Info

Publication number
RU2629840C2
RU2629840C2 RU2014125849A RU2014125849A RU2629840C2 RU 2629840 C2 RU2629840 C2 RU 2629840C2 RU 2014125849 A RU2014125849 A RU 2014125849A RU 2014125849 A RU2014125849 A RU 2014125849A RU 2629840 C2 RU2629840 C2 RU 2629840C2
Authority
RU
Russia
Prior art keywords
imaging
visualization
patient
heart
compound
Prior art date
Application number
RU2014125849A
Other languages
English (en)
Russian (ru)
Other versions
RU2014125849A (ru
Inventor
Мартин Йоханссон
Original Assignee
Респираториус Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Респираториус Аб filed Critical Респираториус Аб
Publication of RU2014125849A publication Critical patent/RU2014125849A/ru
Application granted granted Critical
Publication of RU2629840C2 publication Critical patent/RU2629840C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2014125849A 2011-12-22 2012-12-18 Контрастное вещество для визуализации перфузии миокарда RU2629840C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161579113P 2011-12-22 2011-12-22
SE1151249-8 2011-12-22
SE1151249 2011-12-22
US61/579,113 2011-12-22
PCT/SE2012/051421 WO2013095273A1 (en) 2011-12-22 2012-12-18 Contrast agent for imagining myocardial perfusion

Publications (2)

Publication Number Publication Date
RU2014125849A RU2014125849A (ru) 2016-02-10
RU2629840C2 true RU2629840C2 (ru) 2017-09-04

Family

ID=48668967

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014125849A RU2629840C2 (ru) 2011-12-22 2012-12-18 Контрастное вещество для визуализации перфузии миокарда

Country Status (15)

Country Link
US (2) US9295738B2 (enExample)
EP (1) EP2793952B1 (enExample)
JP (1) JP6140187B2 (enExample)
KR (1) KR101931792B1 (enExample)
CN (1) CN104114191A (enExample)
AU (1) AU2012354223B2 (enExample)
BR (1) BR112014015124A2 (enExample)
CA (1) CA2859773C (enExample)
ES (1) ES2687234T3 (enExample)
IL (1) IL233219A (enExample)
MX (1) MX356258B (enExample)
RU (1) RU2629840C2 (enExample)
SG (1) SG11201403429YA (enExample)
WO (1) WO2013095273A1 (enExample)
ZA (1) ZA201405199B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9955876B2 (en) * 2016-09-08 2018-05-01 Raul Chirife Device and method for assessment of left ventricular ejection fraction and other parameters of cardiac performance
CN107233585B (zh) * 2017-06-09 2021-01-22 四川大学华西医院 黄连素或其衍生物在制备心肌灌注显像剂中的用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079391A2 (en) * 2004-02-13 2005-09-01 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
WO2007021858A2 (en) * 2005-08-10 2007-02-22 Bristol-Myers Squibb Pharma Company Methods of making radiolabeled tracers and precursors thereof
WO2010097410A1 (en) * 2009-02-24 2010-09-02 Respiratorius Ab Novel bronchodilating diazaheteroaryls

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932272B2 (en) 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079391A2 (en) * 2004-02-13 2005-09-01 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
WO2007021858A2 (en) * 2005-08-10 2007-02-22 Bristol-Myers Squibb Pharma Company Methods of making radiolabeled tracers and precursors thereof
WO2010097410A1 (en) * 2009-02-24 2010-09-02 Respiratorius Ab Novel bronchodilating diazaheteroaryls

Also Published As

Publication number Publication date
CN104114191A (zh) 2014-10-22
MX356258B (es) 2018-05-16
HK1201459A1 (en) 2015-09-04
US20160101195A1 (en) 2016-04-14
JP2015500873A (ja) 2015-01-08
RU2014125849A (ru) 2016-02-10
US9687565B2 (en) 2017-06-27
IL233219A (en) 2016-08-31
CA2859773A1 (en) 2013-06-27
WO2013095273A1 (en) 2013-06-27
CA2859773C (en) 2020-09-01
KR101931792B1 (ko) 2019-03-13
ES2687234T3 (es) 2018-10-24
AU2012354223B2 (en) 2017-03-16
EP2793952B1 (en) 2018-06-13
US20140341808A1 (en) 2014-11-20
JP6140187B2 (ja) 2017-05-31
US9295738B2 (en) 2016-03-29
EP2793952A1 (en) 2014-10-29
IL233219A0 (en) 2014-08-31
EP2793952A4 (en) 2015-09-09
BR112014015124A2 (pt) 2017-06-13
SG11201403429YA (en) 2014-07-30
KR20140107411A (ko) 2014-09-04
AU2012354223A1 (en) 2014-07-03
MX2014007491A (es) 2015-02-17
ZA201405199B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
CN106977429B (zh) 用于合成和使用造影剂的组合物、方法和系统
ES2749640T3 (es) Análogos de octreotato radiomarcados como trazadores de PET
JP6987840B2 (ja) Ｉｄｏ１酵素イメージングのための放射性リガンド
US20240156998A1 (en) Radiolabeled ligands for targeted pet/spect imaging and methods of their use
US20240042066A1 (en) Fibroblast activation protein inhibitor
JP2002525325A (ja) 放射標識化ニューロキニン−１受容体拮抗薬
RU2629840C2 (ru) Контрастное вещество для визуализации перфузии миокарда
US7731940B2 (en) Compositions and methods related to serotonin 5-HT1A receptors
CA2911307C (en) Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging
HK1201459B (en) Contrast agent for imagining myocardial perfusion
US11065349B2 (en) 18F labeled BODIPY dye and its derivatives for PET imaging of heart perfusion and others
US20160058895A1 (en) Radiolabeled gnrh antagonists as pet imaging agents
CN113387896B (zh) 一种4-（2-氯芳基）喹唑啉-2-酰胺衍生物及其应用
CN103974947A (zh) 可用于体内成像的5ht1a拮抗剂
KR102403970B1 (ko) 카르복시산이 도입된 psma-표적 화합물 및 그의 용도
JP6488045B2 (ja) アセチルコリン小胞トランスポーターの検出に適した化合物
JP6041751B2 (ja) スチリルピリジン誘導体化合物
JP6496101B2 (ja) アセチルコリン小胞トランスポーターの検出に適した化合物
Popko et al. c12) United States Patent
HK1241356A1 (en) Compositions, methods and systems for the synthesis and use of imaging agents
JP2014218454A (ja) スチリルピリジン誘導体化合物